Gang Zhou

H. Levitsky, L. Luznik, E. Fuchs, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines.

C. Drake, H. Levitsky, Gang Zhou, 2006, Blood.

IFN Regulatory Factor 8 Represses GM-CSF Expression in T Cells To Affect Myeloid Cell Lineage Differentiation

M. Merad, Chen-feng Qi, K. Ozato, 2015, The Journal of Immunology.

Adjuvant IL-7 potentiates adoptive T cell therapy by amplifying and sustaining polyfunctional antitumor CD4+ T cells

D. Munn, L. Bryan, Yang Cao, 2017, Scientific Reports.

Depleting tumor-specific Tregs at a single site eradicates disseminated tumors.

Michael R. Green, H. Kohrt, R. Luong, 2013, The Journal of clinical investigation.

CD4+ T Cells Pass Through an Effector Phase During the Process of In Vivo Tolerance Induction

C. Drake, D. Pardoll, D. Huso, 2003, The Journal of Immunology.

Lineage Differentiation Expression in T Cells To Affect Myeloid Cell IFN Regulatory Factor 8 Represses GM-CSF

M. Merad, Chen-feng Qi, K. Ozato, 2015 .

Indomethacin-induced oxidative stress enhances death receptor 5 signaling and sensitizes tumor cells to adoptive T-cell therapy

G. Piazza, D. Munn, R. Bollag, 2022, Journal for ImmunoTherapy of Cancer.

Tolerance Induction Phase During the Process of In Vivo T Cells Pass Through an Effector + CD 4

C. Drake, D. Pardoll, D. Huso, 2003 .

Presentation of Acquired Peptide-MHC Class II Ligands by CD4+ Regulatory T Cells or Helper Cells Differentially Regulates Antigen-Specific CD4+ T Cell Response

Jie Fu, H. Levitsky, Gang Zhou, 2011, The Journal of Immunology.

Cell Response + Antigen-Specific CD 4 Helper Cells Differentially Regulates Regulatory T Cells or + II Ligands by CD 4 Presentation of Acquired Peptide-MHC Class

Gang Zhou, Zhi-Chun Ding, 2011 .

Cytotoxic Chemotherapy and CD4+ Effector T Cells: An Emerging Alliance for Durable Antitumor Effects

Gang Zhou, Zhi-Chun Ding, 2012, Clinical & developmental immunology.

H3K4me3 mediates the NF-κB p50 homodimer binding to the pdcd1 promoter to activate PD-1 transcription in T cells

Kebin Liu, E. Celis, T. Kumai, 2018, Oncoimmunology.

Vps4A functions as a tumor suppressor by regulating the secretion and uptake of exosomal microRNAs in human hepatoma cells

Li-hong Lv, Guo-lin Li, Jun Min, 2015, Hepatology.

Oxidative Stress in the Tumor Microenvironment and Its Relevance to Cancer Immunotherapy

Gang Zhou, Zhi-Chun Ding, Nada S. Aboelella, 2021, Cancers.

Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade

M. Thangaraju, A. Arbab, R. Kolhe, 2017, Nature Communications.

Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes

Kebin Liu, Wei-ling Xiao, Asha Nayak-Kapoor, 2019, Journal of Immunotherapy for Cancer.

The Stress-responsive Gene ATF3 Regulates the Histone Acetyltransferase Tip60

H. Ding, Yi Tang, Junran Zhang, 2015, Nature Communications.

Suppression of Colon Tumorigenesis in Mutant Apc Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin

Ashley S. Lindsey, G. Piazza, H. Cooper, 2021, Cancer Prevention Research.

PDE5 and PDE10 inhibition activates cGMP/PKG signaling to block Wnt/β-catenin transcription, cancer cell growth, and tumor immunity.

M. Boyd, G. Piazza, A. Keeton, 2020, Drug discovery today.

Immunostimulatory Effects of Melphalan and Usefulness in Adoptive Cell Therapy with Antitumor CD4+ T Cells.

M. Kuczma, Gang Zhou, Zhi-Chun Ding, 2016, Critical reviews in immunology.

Polyfunctional CD4⁺ T cells are essential for eradicating advanced B-cell lymphoma after chemotherapy.

D. Munn, A. Mellor, Lei Huang, 2012, Blood.

Natural Regulatory T Cells and De Novo-Induced Regulatory T Cells Contribute Independently to Tumor-Specific Tolerance1

H. Levitsky, Gang Zhou, Hyam I. Levitsky, 2007, The Journal of Immunology.

Towards Curative Cancer Immunotherapy: Overcoming Posttherapy Tumor Escape

H. Levitsky, Gang Zhou, 2012, Clinical & developmental immunology.

Immunosuppressive myeloid cells induced by chemotherapy attenuate antitumor CD4+ T-cell responses through the PD-1-PD-L1 axis.

D. Munn, M. Mack, Kebin Liu, 2014, Cancer research.

Alteration of Tumor Metabolism by CD4+ T Cells Leads to TNF-α-Dependent Intensification of Oxidative Stress and Tumor Cell Death.

D. Munn, Kebin Liu, W. Pi, 2018, Cell metabolism.

Enhancing anticancer activity of checkpoint immunotherapy by targeting RAS

G. Piazza, A. Keeton, T. Randall, 2020, MedComm.

Reciprocal Changes in Tumor Antigenicity and Antigen-specific T Cell Function during Tumor Progression

H. Levitsky, Zhengbin Lu, A. Marson, 2004, The Journal of experimental medicine.

Tumor PD-L1 engages myeloid PD-1 to suppress type I interferon to impair cytotoxic T lymphocyte recruitment.

D. Munn, Dafeng Yang, Kebin Liu, 2023, Cancer cell.

FAP‐Targeted Photodynamic Therapy Mediated by Ferritin Nanoparticles Elicits an Immune Response against Cancer Cells and Cancer Associated Fibroblasts

Zibo Li, Zipeng Zhen, F. Avci, 2020, Advanced functional materials.

The Monocytes That Repopulate in Mice After Cyclophosphamide Treatment Acquire a Neutrophil Precursor Gene Signature and Immunosuppressive Activity

Huidong Shi, L. Bryan, Gang Zhou, 2021, Frontiers in Immunology.

Chemotherapy-induced myeloid suppressor cells and antitumor immunity: The Janus face of chemotherapy in immunomodulation

D. Munn, Gang Zhou, Zhi-Chun Ding, 2014, Oncoimmunology.

Erratum: Depleting tumor-specific Tregs at a single site eradicates disseminated tumors (Journal of Clinical Investigation (2013) 123:11 (4980) DOI:10.1172/JCI73340)

Michael R. Green, H. Kohrt, R. Luong, 2013 .

IRAK1-regulated IFN-γ signaling induces MDSC to facilitate immune evasion in FGFR1-driven hematological malignancies

J. Cowell, R. Pacholczyk, Yun Liu, 2021, Molecular Cancer.

Near-infrared Light Triggered Activation of Pro-drug Combination Cancer Therapy and Induction of Immunogenic Cell Death.

Pengyu Chen, Yuxin Cai, Wen Yang, 2021, International journal of pharmaceutics.

Novel Pan-RAS Inhibitor ADT-007 Induces Tumor Regression in Mouse Models of GI Cancer

M. Boyd, G. Piazza, I. Babic, 2023, bioRxiv.

Adjuvant IL-7 potentiates adoptive T cell therapy by amplifying and sustaining polyfunctional antitumor CD4+ T cells

D. Munn, L. Bryan, Yang Cao, 2017, Scientific Reports.

Targeting cGMP/PKG signaling for the treatment or prevention of colorectal cancer with novel sulindac derivatives lacking cyclooxygenase inhibitory activity

G. Piazza, A. Keeton, D. Buchsbaum, 2020 .

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines.

C. Drake, H. Levitsky, Gang Zhou, 2006, Blood.

T Cells + Tumor-specific Cd4 Efficacy of Adoptive Immunotherapy Using Alkylating Agent Melphalan Augments The

A. Mellor, H. Lemos, Chufeng Liu, 2022 .

Local Treg Immunomodulation Cures Metastatic Lymphoma Including CNS Sites

H. Kohrt, R. Luong, V. Tse, 2011 .